243 related articles for article (PubMed ID: 1325033)
1. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
Mol Pharmacol; 1992 Aug; 42(2):347-55. PubMed ID: 1325033
[TBL] [Abstract][Full Text] [Related]
2. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
Eur J Biochem; 1992 Jul; 207(1):239-46. PubMed ID: 1321043
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor.
Svoboda M; Tastenoy M; Ciccarelli E; Stiévenart M; Christophe J
Biochem Biophys Res Commun; 1993 Sep; 195(2):881-8. PubMed ID: 8396930
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Nilsson SF; De Neef P; Robberecht P; Christophe J
Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
Vandermeers A; Vandenborre S; Hou X; de Neef P; Robberecht P; Vandermeers-Piret MC; Christophe J
Eur J Biochem; 1992 Sep; 208(3):815-9. PubMed ID: 1327769
[TBL] [Abstract][Full Text] [Related]
7. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
8. Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
Cavallaro S; D'Agata V; Guardabasso V; Travali S; Stivala F; Canonico PL
Mol Pharmacol; 1995 Jul; 48(1):56-62. PubMed ID: 7623775
[TBL] [Abstract][Full Text] [Related]
9. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
10. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
Buscail L; Gourlet P; Cauvin A; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
FEBS Lett; 1990 Mar; 262(1):77-81. PubMed ID: 2156735
[TBL] [Abstract][Full Text] [Related]
11. The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes.
Robberecht P; Woussen-Colle MC; De Neef P; Gourlet P; Buscail L; Vandermeers A; Vandermeers-Piret MC; Christophe J
FEBS Lett; 1991 Jul; 286(1-2):133-6. PubMed ID: 1650711
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
13. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes.
Ando E; Nokihara K; Naruse S; Wray V
Biomed Pept Proteins Nucleic Acids; 1996; 2(2):41-6. PubMed ID: 9346825
[TBL] [Abstract][Full Text] [Related]
14. Differential signal transduction by five splice variants of the PACAP receptor.
Spengler D; Waeber C; Pantaloni C; Holsboer F; Bockaert J; Seeburg PH; Journot L
Nature; 1993 Sep; 365(6442):170-5. PubMed ID: 8396727
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor.
Ogi K; Miyamoto Y; Masuda Y; Habata Y; Hosoya M; Ohtaki T; Masuo Y; Onda H; Fujino M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1511-21. PubMed ID: 7902709
[TBL] [Abstract][Full Text] [Related]
16. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
[TBL] [Abstract][Full Text] [Related]
17. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
Suda K; Smith DM; Ghatei MA; Murphy JK; Bloom SR
J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements for the occupancy of rat brain PACAP receptors and adenylate cyclase activation.
Hou X; Vandermeers A; Gourlet P; Vandermeers-Piret MC; Robberecht P
Neuropharmacology; 1994 Oct; 33(10):1189-95. PubMed ID: 7862254
[TBL] [Abstract][Full Text] [Related]
19. Photoaffinity labeling analysis of the interaction of pituitary adenylate-cyclase-activating polypeptide (PACAP) with the PACAP type I receptor.
Cao YJ; Kojro E; Gimpl G; Jasionowski M; Kasprzykowski F; Lankiewicz L; Fahrenholz F
Eur J Biochem; 1997 Mar; 244(2):400-6. PubMed ID: 9119005
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23.
Vertongen P; Ciccarelli E; Woussen-Colle MC; De Neef P; Robberecht P; Cauvin A
Endocrinology; 1994 Oct; 135(4):1537-42. PubMed ID: 7925114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
